Human internal thoracic arteries from diabetic patients are resistant to endothelial dysfunction

Fundamental and Clinical Pharmacology

Volumn 23, Issue 5, 2009, Pages 567-572

  Grapow, Martin T R ^a   Reineke, David C ^b   Kern, Thomas ^c   Müller Schweinitzer, Else ^a   Carrel, Thierry ^b   Eckstein, Friedrich S ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b BERN UNIVERSITY HOSPITAL   (Switzerland)

^c UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Diabetes; Endothelial dysfunction; Internal thoracic artery; Organ bath; Vascular function

Indexed keywords

ACETYLCHOLINE; ENDOTHELIN 1; ENDOTHELIUM DERIVED RELAXING FACTOR; NORADRENALIN; POTASSIUM CHLORIDE;

ADULT; AGED; ARTERY GRAFT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DEPOLARIZATION; DIABETES MELLITUS; DIABETIC PATIENT; ENDOTHELIAL DYSFUNCTION; FEMALE; HUMAN; INTERNAL MAMMARY ARTERY; MALE; PRIORITY JOURNAL;

ADULT; AGED; CALCIUM; DIABETES MELLITUS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; MAMMARY ARTERIES; MIDDLE AGED; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE SYNTHASE; SUPEROXIDE DISMUTASE; VASOCONSTRICTOR AGENTS; VASODILATION; VASODILATOR AGENTS;

EID: 69949186798     PISSN: 07673981     EISSN: 14728206     Source Type: Journal    
DOI: 10.1111/j.1472-8206.2009.00707.x     Document Type: Article

References (41)

1. Thourani V.H., Weintraub W.S., Stein B. et al. Influence of diabetes mellitus on early and late outcome after coronary artery bypass grafting. Ann. Thorac. Surg. (1999) 67 1045 1052.
2. Carson J.L., Scholz P.M., Chen A.Y., Peterson E.D., Gold J., Schneider S.H. Diabetes mellitus increases short-term mortality and morbidity in patients undergoing coronary artery bypass graft surgery. J. Am. Coll. Cardiol. (2002) 40 418 423.
3. Tooke J.E. Possible pathophysiological mechanisms for diabetic angiopathy in type 2 diabetes. J. Diabetes Complicat. (2000) 14 197 200.
4. Hayoz D., Ziegler T., Brunner H.R., Ruiz J. Diabetes mellitus and vascular lesions. Metabolism (1998) 47 16 19.
5. De Vriese A.S., Verbeuren T.J., Van de Voorde J., Lameire N.H., Vanhoutte P.M. Endothelial dysfunction in diabetes. Br. J. Pharmacol. (2000) 130 963 974.
6. Kay H.R., Korns M.E., Flemma R.J., Tector A.J., Lepley D. Jr. Atherosclerosis of the internal mammary artery. Ann. Thorac. Surg. (1976) 21 504 507.
7. Sakata N., Takeuchi K., Noda K. et al. Calcification of the medial layer of the internal thoracic artery in diabetic patients: relevance of glycoxidation. J. Vasc. Res. (2003) 40 567 574.
8. Mahadevan V.S., Campbell M., McKeown P.P., Bayraktutan U. Internal mammary artery smooth muscle cells resist migration and possess high antioxidant capacity. Cardiovasc. Res. (2006) 72 60 68.
9. Sons H.J., Godehardt E., Kunert J., Losse B., Bircks W. Internal thoracic artery: prevalence of atherosclerotic changes. J. Thorac. Cardiovasc. Surg. (1993) 106 1192 1195.
10. Kaufer E., Factor S.M., Frame R., Brodman R.F. Pathology of the radial and internal thoracic arteries used as coronary artery bypass grafts. Ann. Thorac. Surg. (1997) 63 1118 1122.
11. Ruengsakulrach P., Sinclair R., Komeda M., Raman J., Gordon I., Buxton B. Comparative histopathology of radial artery versus internal thoracic artery and risk factors for development of intimal hyperplasia and atherosclerosis. Circulation (1999) 100 II139 II144.
12. Muller-Schweinitzer E., Gilles H., Grapow M., Kern T., Reineke D., Zerkowski H.R. Attenuation of lipopolysaccharide-induced hyperreactivity of human internal mammary arteries by melatonin. J. Pineal Res. (2004) 37 92 97.
13. Ang C., Hillier C., Cameron A.D., Greer I.A., Lumsden M.A. The effect of type 1 diabetes mellitus on vascular responses to endothelin-1 in pregnant women. J. Clin. Endocrinol. Metab. (2001) 86 4939 4942.
14. McIntyre C.A., Hadoke P.W., Williams B.C., Lindsay R.M., Elliott A.I., McKnight J.A. Selective enhancement of sensitivity to endothelin-1 despite normal endothelium-dependent relaxation in subcutaneous resistance arteries isolated from patients with Type I diabetes. Clin. Sci. (Lond.) (2001) 100 311 318.
15. 2+ distribution. Diabetes (1999) 48 1323 1330.
16. Guzik T.J., Mussa S., Gastaldi D. et al. Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation (2002) 105 1656 1662.
17. Ergul A., Johansen J.S., Stromhaug C. et al. Vascular dysfunction of venous bypass conduits is mediated by reactive oxygen species in diabetes: role of endothelin-1. J. Pharmacol. Exp. Ther. (2005) 313 70 77.
18. Anderson T.J., Uehata A., Gerhard M.D. et al. Close relation of endothelial function in the human coronary and peripheral circulations. J. Am. Coll. Cardiol. (1995) 26 1235 1241.
19. Jansson P.A. Endothelial dysfunction in insulin resistance and type 2 diabetes. J. Intern. Med. (2007) 262 173 183.
20. Giannattasio C., Failla M., Piperno A. et al. Early impairment of large artery structure and function in type I diabetes mellitus. Diabetologia (1999) 42 987 994.
21. Zenere B.M., Arcaro G., Saggiani F., Rossi L., Muggeo M., Lechi A. Noninvasive detection of functional alterations of the arterial wall in IDDM patients with and without microalbuminuria. Diabetes Care (1995) 18 975 982.
22. Preik M., Kelm M., Rosen P., Tschope D., Strauer B.E. Additive effect of coexistent type 2 diabetes and arterial hypertension on endothelial dysfunction in resistance arteries of human forearm vasculature. Angiology (2000) 51 545 554.
23. Perticone F., Maio R., Sciacqua A. et al. Endothelial dysfunction and C-reactive protein are risk factors for diabetes in essential hypertension. Diabetes (2008) 57 167 171.
24. Yasuda S., Miyazaki S., Kanda M. et al. Intensive treatment of risk factors in patients with type-2 diabetes mellitus is associated with improvement of endothelial function coupled with a reduction in the levels of plasma asymmetric dimethylarginine and endogenous inhibitor of nitric oxide synthase. Eur. Heart J. (2006) 27 1159 1165.
25. Calver A., Collier J., Vallance P. Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes. J. Clin. Invest. (1992) 90 2548 2554.
26. Smits P., Kapma J.A., Jacobs M.C., Lutterman J., Thien T. Endothelium-dependent vascular relaxation in patients with type I diabetes. Diabetes (1993) 42 148 153. (Pubitemid 23013807)
27. Lambert J., Aarsen M., Donker A.J., Stehouwer C.D. Endothelium-dependent and -independent vasodilation of large arteries in normoalbuminuric insulin-dependent diabetes mellitus. Arterioscler. Thromb. Vasc. Biol. (1996) 16 705 711.
28. Johnstone M.T., Creager S.J., Scales K.M., Cusco J.A., Lee B.K., Creager M.A. Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation (1993) 88 2510 2516.
29. Giugliano D., Marfella R., Coppola L. et al. Vascular effects of acute hyperglycemia in humans are reversed by L-arginine. Evidence for reduced availability of nitric oxide during hyperglycemia. Circulation (1997) 95 1783 1790.
30. Furchgott R.F., Zawadzki J.V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature (1980) 288 373 376.
31. Palmer R.M., Ferrige A.G., Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature (1987) 327 524 526. (Pubitemid 17085822)
32. Moncada S., Gryglewski R., Bunting S., Vane J.R. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature (1976) 263 663 665.
33. Taylor S.G., Weston A.H. Endothelium-derived hyperpolarizing factor: a new endogenous inhibitor from the vascular endothelium. Trends Pharmacol. Sci. (1988) 9 272 274.
34. Pompilio G., Rossoni G., Alamanni F. et al. Comparison of endothelium-dependent vasoactivity of internal mammary arteries from hypertensive, hypercholesterolemic, and diabetic patients. Ann. Thorac. Surg. (2001) 72 1290 1297.
35. Okon E.B., Chung A.W., Rauniyar P. et al. Compromised arterial function in human type 2 diabetic patients. Diabetes (2005) 54 2415 2423.
36. Karasu C., Soncul H., Altan V.M. Effects of non-insulin dependent diabetes mellitus on the reactivity of human internal mammary artery and human saphenous vein. Life Sci. (1995) 57 103 112.
37. Wendler O., Landwehr P., Bandner-Risch D., Georg T., Schafers H.J. Vasoreactivity of arterial grafts in the patient with diabetes mellitus: investigations on internal thoracic artery and radial artery conduits. Eur. J. Cardiothorac. Surg. (2001) 20 305 311.
38. Ozkan S., Akay T.H., Gultekin B. et al. Atherosclerosis of radial and internal thoracic arteries used in coronary bypass: atherosclerosis in arterial grafts. J. Card. Surg. (2007) 22 385 389.
39. Rubanyi G.M., Vanhoutte P.M. Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. Am. J. Physiol. (1986) 250 H822 H827.
40. Griendling K.K., FitzGerald G.A. Oxidative stress and cardiovascular injury: Part II: animal and human studies. Circulation (2003) 108 2034 2040.
41. Griendling K.K., FitzGerald G.A. Oxidative stress and cardiovascular injury: Part I: basic mechanisms and in vivo monitoring of ROS. Circulation (2003) 108 1912 1916.